GL1X · GenesisL1 explorer

Research workbench

Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 ångströms resolution

Analyse Crystal structure of cleaved equine leucocyte elastase inhibitor determined at… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1HLE
Type
protein
Length
375 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Horse leukocyte elastase inhibitor
UniProt
P05619
Ligands
ACE, CA
Pockets
1 · best druggability 0.42

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHorse leukocyte elastase inhibitorprotein34435% helix, 35% strandP05619
BHorse leukocyte elastase inhibitorprotein310% helix, 61% strandP05619

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.420.8212empty

Interfaces

1 interface between chains.

  • A–B · 2493 Ų buried · 44 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 1HLE · Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95… · the same entry in another collection · chain A against A, TM-score 1.00
  • P05619 · AlphaFold monomer V2.0 prediction for leukocyte elastase inhibitor (P05619) · a predicted model of the same protein · chain B against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.